SCHEMBL4853060

SCHEMBL4853060

Cc1cc(C)cc(-c2ccc(OCCN(C)C)c(C(=O)/C=C/c3ccccc3CN(C)C)c2)c1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SYK P43405 2/20 0.42
HRH1 P35367 1/20 0.40
SLC6A9 P48067 6/20 0.39
ESR1 P03372 1/20 0.38
BCHE P06276 2/20 0.38
ACHE P22303 2/20 0.38
AR P10275 1/20 0.37
PTGER1 P34995 2/20 0.37
PTGER4 P35408 2/20 0.37
PTGER3 P43115 2/20 0.37
PTGER2 P43116 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
ATM Q13315 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4852981 1.00 SYK (0.42) SYKHRH1SLC6A9ESR1BCHE
SCHEMBL4848478 0.94 SYK (0.40) SYKHRH1SLC6A9ESR1BCHE
SCHEMBL4851055 0.94 SYK (0.40) SYKHRH1SLC6A9ESR1BCHE
SCHEMBL4852871 0.94 SLC6A9 (0.45) SYKHRH1SLC6A9ESR1BCHE
SCHEMBL4850155 0.94 SLC6A9 (0.45) SYKHRH1SLC6A9ESR1BCHE
SCHEMBL4856320 0.93 SLC6A9 (0.43) HRH1SLC6A9ESR1BCHEACHE
SCHEMBL4854564 0.93 SLC6A9 (0.43) HRH1SLC6A9ESR1BCHEACHE
SCHEMBL4852245 0.91 SYK (0.45) SYKHRH1SLC6A9BCHEACHE
SCHEMBL4849808 0.91 SYK (0.45) SYKHRH1SLC6A9BCHEACHE
SCHEMBL4849737 0.91 HRH1 (0.39) SYKHRH1SLC6A9ESR1BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed